carbostyril has been researched along with Agoraphobia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harada, T; Ishigooka, J; Sakamoto, K; Yamada, K | 1 |
| Kollias, K; Konstantakopoulos, G; Nathanailidis, E; Oulis, P; Tsiamoura, M | 1 |
2 other study(ies) available for carbostyril and Agoraphobia
| Article | Year |
|---|---|
Aripiprazole augmentation for a patient with partial remission of panic disorder.
Topics: Adult; Agoraphobia; Antipsychotic Agents; Aripiprazole; Drug Therapy, Combination; Humans; Male; Panic Disorder; Paroxetine; Piperazines; Quinolones; Remission Induction; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2009 |
Low-dose aripiprazole in the treatment of selective serotonin reuptake inhibitors-induced orofacial and buccal dystonia.
Topics: Adult; Agoraphobia; Antipsychotic Agents; Aripiprazole; Dystonia; Face; Female; Humans; Panic Disorder; Paroxetine; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors | 2012 |